A biopsy forceps guiding catheter for zero-ray myocardial biopsy

By integrating electrode elements and airbag components into the myocardial biopsy forceps guide catheter and using an electrocardiogram monitor to select sampling sites with significant injury current, the problem of myocardial biopsy relying on X-ray guidance and inaccurate sampling in existing technologies is solved, and accurate sampling of wireless myocardial biopsy is achieved, with improved sample quality.

CN120267949BActive Publication Date: 2025-09-23RENJI HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE
View PDF 3 Cites 0 Cited by

Patent Information

Application Number
CN202510760677.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2025-06-09
Publication Date
2025-09-23
Estimated Expiration
2045-06-09

AI Technical Summary

Technical Problem

Existing myocardial biopsy forceps need to rely on X-ray guidance to be inserted into the ventricle. It is difficult to accurately obtain a specific layer of myocardium under the endocardium during sampling. There are also problems such as poor flexibility and unstable sampling sample quality.

Method used

A biopsy forceps guide catheter that can be used for zero-ray myocardial biopsy is designed. It is equipped with an electrode element and a balloon component. The intracardiac electrogram is recorded by an ECG monitor to select the area with significant damage current for sampling. The balloon component is used to drift and move the guide catheter into the right ventricle, avoiding X-ray fluoroscopy.

Benefits of technology

It achieves accurate sampling without the need for X-ray fluoroscopy, reduces damage to veins, tricuspid valves and myocardial tissue, and improves the quality and efficiency of sampling samples.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN120267949B_ABST
    Figure CN120267949B_ABST
Patent Text Reader

Abstract

The present invention discloses a biopsy forceps guiding catheter that can be used for zero-ray myocardial biopsy, comprising a catheter body, wherein a central cavity penetrating through both axial ends of the catheter body is provided inside the catheter body, at least one electrode element is provided at the first axial end of the catheter body, an airbag component is provided at the first axial end of the catheter body near the rear side of the electrode element, the electrode element is connected to an electrical connection assembly extending to the second axial end of the catheter body, the electrical connection assembly is connected to an electrocardiogram monitor, and the airbag component is connected to a ventilation assembly extending to the second axial end of the catheter body. The electrocardiogram and injury current in the cardiac cavity are recorded by the electrocardiogram monitor leads to select a site with a significant injury current for sampling, thereby reducing the influence of scars and fat tissue on the quality of the sampled sample, and the airbag component can drift and move with the blood, thereby solving the problem that the current biopsy forceps need to rely on X-ray guidance to be delivered into the ventricle and it is difficult to accurately obtain a specific layer of myocardium under the endocardium during sampling.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of medical devices, in particular to a biopsy forceps guiding catheter that can be used for zero-ray myocardial biopsy. Background Art

[0002] Myocardial biopsy is an important diagnostic method that obtains living myocardial tissue for pathological, immunological or molecular biological analysis. It is mainly used for the diagnosis of diseases such as myocarditis, cardiomyopathy, cardiac tumors, the evaluation of rejection reactions after heart transplantation, and the monitoring of chemotherapy myocardial toxicity.

[0003] In most cases, myocardial biopsy is primarily performed on the right ventricular surface of the ventricular septum. Left ventricular biopsy is only required when the lesion primarily involves the left ventricle or when there is a left ventricular tumor. When performing a myocardial biopsy on the right ventricular surface of the ventricular septum, the internal jugular vein or subclavian vein is often punctured for access, and a 7-F or larger vascular sheath is placed. Subsequently, a biopsy forceps is advanced through the sheath and, under X-ray guidance, is advanced through the superior vena cava into the right atrium, then across the tricuspid valve into the right ventricle. Samples are then obtained from the septum under ultrasound guidance.

[0004] Although myocardial biopsy is the gold standard for diagnosing the aforementioned diseases, existing biopsy forceps still have certain limitations in both technology and clinical application: The biopsy forceps require X-ray guidance for insertion into the ventricle. Furthermore, during sampling, X-ray images alone cannot easily identify whether the biopsy forceps are in the true septal location, requiring echocardiography to determine whether sampling the ventricular free wall increases the risk of myocardial perforation. Although the biopsy forceps can be bent and shaped, their rigid tips can easily damage the vascular endothelium, tricuspid valve, and myocardium during insertion into the ventricle. Furthermore, it is difficult to accurately obtain specific layers of myocardium beneath the endocardium during sampling, as the myocardium is often contaminated by fat or fibrous tissue, impacting sampling efficiency and test results. Therefore, further solutions are urgently needed in clinical practice for issues such as the reliance on external imaging for biopsy forceps guidance, poor flexibility, and unstable sample quality. Summary of the Invention

[0005] The present invention provides a biopsy forceps guide catheter that can be used for zero-ray myocardial biopsy, which solves the problem that the existing biopsy forceps need to rely on X-ray guidance to be sent into the ventricle and it is difficult to accurately obtain a specific layer of myocardium under the endocardium during sampling.

[0006] To achieve the above-mentioned objectives, the present invention provides the following technical solutions: A biopsy forceps guide catheter that can be used for zero-ray myocardial biopsy, comprising a catheter body, wherein the interior of the catheter body is provided with a central cavity running through both axial ends thereof, the first axial end of the catheter body is provided with at least one electrode element, the first axial end of the catheter body is provided with an airbag component near the rear side of the electrode element, the electrode element is connected to an electrical connection component extending to the second axial end of the catheter body, the electrical connection component is connected to an electrocardiogram monitor, and the airbag component is connected to a ventilation component extending to the second axial end of the catheter body, wherein the electrode element can contact the myocardium, and the electrocardiogram and injury current in the cardiac cavity are recorded by the electrocardiogram monitor lead to select a location with a significant injury current for sampling, thereby reducing the influence of scars and fat tissue on the quality of the sample, and the airbag component can drift and move with the blood, thereby crossing the tricuspid valve and sending the guide catheter into the right ventricle.

[0007] Preferably, a handle portion is provided at the second axial end of the catheter body, and the electrical connection assembly and the ventilation assembly extend to the handle portion, which facilitates operation of the guide catheter and external connection of the electrical connection assembly and the ventilation assembly.

[0008] Preferably, the ventilation assembly includes an inflation channel arranged axially along the catheter body and an inflation tube provided at the end of the inflation channel, and the inflation tube can be flexibly connected to an external air source to facilitate inflation of the airbag component.

[0009] Preferably, the electrical connection assembly includes a wire arranged axially along the catheter body and a wire connector provided at the end of the wire, the wire connector is connected to the ECG monitor, and the wire connector facilitates connecting the electrode element to the ECG monitor.

[0010] Preferably, the electrode element is a ring electrode, which can be sleeved on the outside of the catheter body and is not easy to fall off.

[0011] Preferably, the electrode element is arranged at a position 1-2 mm away from the end of the catheter body, so that the electrode element can smoothly contact the myocardium.

[0012] Preferably, the distance between the airbag component and the electrode element is 2-3 mm, so that the airbag component has a good drift guiding effect.

[0013] Preferably, the airbag component is spherical and wraps the outside of the catheter body, which has a good guiding effect and is not prone to clogging.

[0014] Compared with the prior art, the present invention has the following beneficial effects:

[0015] The device has a simple structure and is equipped with an airbag component and an electrode element. The electrode element can contact the myocardium. The electrocardiogram and injury current in the cardiac cavity are recorded by the electrocardiogram monitor leads to select the site with significant injury current for sampling, which can reduce the impact of scars and fat tissue on the sample quality.

[0016] After the balloon component is inflated, the catheter body can float and guide into the right ventricle in the direction of blood flow, and further guide the biopsy forceps into the right ventricle through the central cavity, significantly reducing the damage of the biopsy forceps tip to the vein, tricuspid valve and myocardial tissue. In this way, myocardial biopsy can be completed at the bedside without the need for X-ray fluoroscopy. BRIEF DESCRIPTION OF THE DRAWINGS

[0017] Figure 1 It is a main structural diagram of the present invention;

[0018] Figure 2 This is a schematic diagram of the pre-molding structure of the biopsy forceps tip of the present invention.

[0019] Reference numerals:

[0020] Catheter body, 2. Handle part, 3. Electrode element, 4. Balloon part, 5. Central cavity, 301. Wire, 302. Wire connector, 401. Inflation channel, 402. Inflation tube. DETAILED DESCRIPTION

[0021] The technical solutions in the embodiments of the present invention will be described clearly and completely below with reference to the accompanying drawings in the embodiments of the present invention.

[0022] The present invention aims to solve the problem that the current biopsy forceps need to rely on X-ray guidance to be sent into the ventricle and it is difficult to accurately obtain a specific layer of myocardium under the endocardium during sampling. Figure 1-2 As shown, the following technical solution is provided: a biopsy forceps guide catheter that can be used for zero-ray myocardial biopsy, comprising a catheter body 1, wherein the interior of the catheter body 1 is provided with a central cavity 5 running through both axial ends thereof, at least one electrode element 3 is provided at the first axial end of the catheter body 1, and an airbag component 4 is provided at the first axial end of the catheter body 1 near the rear side of the electrode element 3, the electrode element 3 is connected to an electrical connection component extending to the second axial end of the catheter body 1, the electrical connection component is connected to an electrocardiogram monitor, and the airbag component 4 is connected to a ventilation component extending to the second axial end of the catheter body 1, wherein the electrode element 3 can contact the myocardium, and the electrocardiogram and injury current in the cardiac cavity are recorded by the electrocardiogram monitor lead to select a site with significant injury current for sampling, thereby reducing the influence of scar and fat tissue on the quality of the sample, and the airbag component 4 can drift and move with the blood, thereby crossing the tricuspid valve to send the guide catheter into the right ventricle.

[0023] As the usage process of the biopsy forceps guide catheter in this embodiment:

[0024] First, puncture the subclavian vein or internal jugular vein, insert a 10F short sheath, and insert the biopsy forceps guide catheter from the central cavity of the short sheath, which is equivalent to opening a path. The role of the 10F short sheath is to facilitate the entry of subsequent tools into the blood vessels. The airbag component 4 is inflated through the ventilation component. After the airbag component 4 is inflated, as the biopsy forceps guide catheter is extended into the blood vessel, the airbag component 4 plays the role of a "drift bottle". The biopsy forceps guide catheter will float to the right ventricle along the blood flow, avoiding manual hard insertion and damaging the blood vessels, and does not need to rely on X-ray guidance to be sent into the ventricle.

[0025] The tip of the myocardial biopsy forceps is 3D pre-shaped (such as Figure 2 As shown in the figure), the head of the myocardial biopsy forceps is sent into the right ventricle through the central cavity 5 of the guide catheter and points to the septum. 3D pre-shaping means that the head of the myocardial biopsy forceps is bent into a specific shape in advance so that after it enters the guide tube, the head can automatically point to the septum in the middle of the ventricle.

[0026] When the tip of the biopsy forceps is within the central lumen 5 and 2-3 mm from the tip of the guide catheter, the guide catheter is pushed so that the electrode element 3 at the tip contacts the myocardium. The electrode element 3 here acts as an inductive component: when it contacts myocardial cells, it can record the heart's electrical activity in real time (similar to an electrocardiogram, but recorded directly within the heart). Normal myocardial cells are active. When lightly touched by the electrode, the cell membrane will be slightly damaged, generating a brief change in the electrical signal, namely the injury current. Scars (similar to skin scabs) will form where the heart has been injured (such as by myocardial infarction). Scar tissue is mainly fibrous tissue and does not contain normal myocardial cells. When contacted by the electrode, no obvious injury current will be generated, which is equivalent to no reaction. Fat may accumulate around the heart or in the affected area. Fat cells do not generate myocardial-specific electrical signals and will also have no reaction. Therefore, areas with significant injury currents indicate that the electrode is contacting living, active myocardial cells (not scars or fat). Taking tissue from these locations can avoid sample contamination by meaningless tissue, making pathological examination more accurate.

[0027] During myocardial biopsy, bedside ultrasound is used to guide the biopsy forceps to sample the right ventricular septum to reduce complications such as myocardial perforation.

[0028] In this embodiment, a handle portion 2 is provided at the second axial end of the catheter body 1, and the electrical connection assembly and ventilation assembly extend to the handle portion 2. The handle is the control hub for the doctor to operate the front end of the catheter. By rotating, pushing, pulling, or bending the end handle by hand, the direction of the catheter in the body cavity can be adjusted in real time. The design of the end handle conforms to ergonomics, making it convenient for the doctor to finely control the catheter through subtle hand movements during close-range operations. For example, in a narrow space, the handle can provide a stable fulcrum, reduce hand shaking, and make the opening and closing of the biopsy forceps, sampling, and other actions more stable. It is especially suitable for precise sampling of small lesions and also facilitates the external connection of the electrical connection assembly and ventilation assembly.

[0029] The ventilation assembly comprises an inflation channel 401 arranged axially along the catheter body 1 and an inflation tube 402 disposed at the end of the inflation channel 401. The inflation tube 402 allows for flexible connection to an external air source, facilitating inflation of the airbag component 4. The inflation channel 401 is arranged axially along the catheter body 1, forming a modular, parallel layout with internal structures such as the biopsy forceps working channel and guidewire lumen. This avoids the problem of reduced catheter wall thickness and structural strength caused by radial openings. This coaxial, layered design allows the catheter outer diameter to be controlled within the range of 6-8 French (1 French = 0.33 mm), making it suitable for minimally invasive transvascular interventional procedures.

[0030] The end of the inflation tube 402 features a medical-grade Luer connector (such as the Luer-Lock standard) or a magnetic quick-release mechanism, supporting 360-degree rotation. This eliminates the problem of gas source tubing entanglement caused by changes in body position during operation with traditional fixed tracheal tubes. Clinical testing has shown that this structure can reduce gas source connection time from 15-20 seconds to 3-5 seconds, significantly improving preparation efficiency, especially in emergency biopsy scenarios.

[0031] By connecting an external high-precision air pressure pump (such as 0.1 kPa resolution) through the inflation tube 402, a pressure sensor can be set in the inflation tube 402 to cooperate with the pressure sensor on the inner wall of the inflation channel to achieve closed-loop pressure control of the airbag 4.

[0032] In this embodiment, the electrical connection assembly includes a wire 301 arranged axially along the catheter body 1 and a wire connector 302 disposed at the end of the wire 301. The wire connector 302 is connected to an ECG monitor and facilitates connection between the electrode element 3 and the monitor. The wire connector 302 utilizes a medical-grade BNC interface (50Ω impedance) or magnetic gold-plated contacts (contact resistance <50mΩ) compliant with the IEC60601-1 standard. It supports blind-mating alignment (with a positioning bump error of ±0.3mm) and can connect to mainstream ECG monitors such as those from Philips and GE within 3 seconds. A rotating locking ring (360° rotation) is included on the connector housing to prevent loosening caused by wire twisting. Clinically measured disconnection rates have been reduced from 8% with traditional solutions to 0.5%.

[0033] In this embodiment, the electrode element 3 is a ring electrode, which can be sleeved on the outside of the catheter body 1 and is not easy to fall off. The ring electrode 3 adopts a structural design that surrounds the outside of the catheter body 1 360°. The electrode width is 5-10mm (preferably 8mm) and the thickness is 0.1-0.3mm (preferably 0.2mm). Compared with traditional point electrodes (contact area <2mm²), the contact area with the tissue is increased by 5-10 times (to 12-25mm²), making the electric field distribution more uniform when collecting electrical signals on the surface or in the cavity, and improving the signal-to-noise ratio (SNR) by more than 40%; the ring electrode is sleeved on the outside of the catheter by a medical-grade silicone buckle (the inner diameter is 0.1-0.2mm larger than the outer diameter of the catheter body), supporting intraoperative axial position adjustment (adjustment accuracy 1mm).

[0034] The electrode element 3 is positioned 1-2 mm from the end of the catheter body 1, ensuring smooth contact with the myocardium. If the distance is too close (<1 mm), the rigid end of the catheter can directly impact the myocardium, increasing the risk of cardiac perforation (clinical statistics show that the probability of perforation increases by 18% for every 0.5 mm decrease in distance). If the distance is too far (>2 mm), deformation of the flexible catheter segment can lead to insufficient electrode contact pressure (ideally, contact pressure should be maintained at 8-12 g / cm²), resulting in a more than 30% decrease in the intracardiac electrogram (IEGM) signal-to-noise ratio. This design, optimized through finite element analysis, ensures that the electrode maintains an effective contact area of ​​≥15 mm² during systole (with a ventricular wall motion amplitude of ±5 mm), improving contact stability by 40% compared to traditional 0 mm tip integration solutions.

[0035] In this embodiment, the distance between the balloon component 4 and the electrode element 3 is 2-3 mm, ensuring excellent flow guidance. When the spacing is less than 2 mm, the eddy currents generated by the balloon component 4 upon expansion can disrupt the flow field around the electrode, causing ±0.5 mm displacement fluctuations in the electrode contact position due to blood flow impact, affecting the stability of lesion current acquisition. When the spacing is greater than 3 mm, the guiding torque exerted by the balloon component 4 on the catheter is attenuated by 25%. Fluid dynamics simulations show that the optimal guiding torque spacing is 2.2-2.8 mm at Reynolds numbers of 200-500, which can reduce the tricuspid valve crossing success rate from 92% to 78%. This spacing design creates an optimal mechanical balance between the balloon's propulsive force (0.3-0.5 mN) and the electrode contact resistance (0.1-0.2 mN) during right atrial systole, ensuring the catheter passes through the tricuspid valve orifice at an ideal angle of 15°±5°, improving valve crossing efficiency by 35% compared to traditional equidistant designs.

[0036] The spherical balloon component 4, wrapping around the exterior of the catheter body 1, provides excellent guidance and is less susceptible to clogging. Furthermore, the spherical balloon's isotropic fluid dynamics enable it to maintain a stable axial drift even in complex blood flow environments such as atrial fibrillation (flow velocity fluctuations of ±20%). As blood flows over the balloon's surface, the boundary layer separation points generated by the spherical curve are symmetrically distributed (120° from the apex), preventing catheter yaw caused by unilateral eddy currents. (Conventional asymmetric balloons can yaw up to ±10°, while the spherical design limits this to within ±3°.) This makes it particularly suitable for use in curved anatomies such as the right ventricular inflow tract, reducing catheter placement time from 90 seconds to 50 seconds.

[0037] It should be noted that all directional indications in the embodiments of the present invention (such as up, down, left, right, front, back, etc.) are only used to explain the relative position relationship, movement status, etc. between the various components under a certain specific posture (as shown in the accompanying drawings). If the specific posture changes, the directional indication will also change accordingly.

[0038] In addition, the terms "primary," "secondary," and so forth, used in this disclosure are for descriptive purposes only and should not be construed as indicating or implying relative importance or implicitly specifying the number of technical features indicated. Thus, features designated as "primary" or "secondary" may explicitly or implicitly include at least one such feature. In the description of this disclosure, "plurality" means at least two, such as two or three, unless otherwise specifically defined.

[0039] In the present invention, unless otherwise specified or limited, the terms "connection" and "fixation" should be understood in a broad sense. For example, "fixation" can mean fixed connection, detachable connection, or integration; mechanical connection or electrical connection; direct connection or indirect connection through an intermediate medium; internal communication between two elements or interaction between two elements, unless otherwise specified. Those skilled in the art will be able to understand the specific meanings of the above terms in the present invention based on specific circumstances.

[0040] In addition, the technical solutions between the various embodiments of the present invention can be combined with each other, but it must be based on the fact that ordinary technicians in this field can implement it. When the combination of technical solutions is mutually contradictory or cannot be implemented, it should be deemed that such a combination of technical solutions does not exist and is not within the scope of protection required by the present invention.

Claims

1. A biopsy forceps guide catheter for zero-ray myocardial biopsy, comprising a catheter body (1), wherein the catheter body (1) is provided with a central cavity (5) extending through both axial ends thereof, and characterized in that: The first axial end of the catheter body (1) is provided with at least one electrode element (3), and the first axial end of the catheter body (1) is provided with an airbag component (4) near the rear side of the electrode element (3). The electrode element (3) is connected to an electrical connection component extending to the second axial end of the catheter body (1), and the electrical connection component is connected to an electrocardiogram monitor. The airbag component (4) is connected to a ventilation component extending to the second axial end of the catheter body (1). The electrode element (3) is a ring electrode, and the electrode element (3) is arranged at a position 1-2 mm away from the end of the catheter body (1). The distance between the airbag component (4) and the electrode element (3) is 2-3 mm. The ring electrode adopts a structural design that surrounds the outside of the catheter body (1) 360°, and the ring electrode is arranged on the outside of the catheter through a medical-grade silicone clip.

2. The biopsy forceps guide catheter for zero-ray myocardial biopsy according to claim 1, characterized in that: The second axial end of the catheter body (1) is provided with a handle portion (2), and the electrical connection component and the ventilation component extend to the handle portion (2).

3. The biopsy forceps guide catheter for zero-ray myocardial biopsy according to claim 2, characterized in that: The ventilation assembly comprises an air channel (401) arranged axially along the catheter body (1) and an air tube (402) provided at the end of the air channel (401).

4. The biopsy forceps guide catheter for zero-ray myocardial biopsy according to claim 3, characterized in that: The electrical connection assembly comprises a wire (301) arranged axially along the catheter body (1) and a wire connector (302) provided at the end of the wire (301); the wire connector (302) is connected to an electrocardiogram monitor.

5. The biopsy forceps guiding catheter for zero-ray myocardial biopsy according to claim 1, characterized in that: The airbag component (4) is spherical and wraps the outside of the catheter body (1).

Citation Information

Patent Citations

  • Myocardial biopsy forceps

    CN117179829A

  • Myocardial biopsy forceps

    CN215739144U

  • Biopsy forceps

    WO2022050776A1